Trial
NCT06199037
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shanghai Hengrui Pharmaceutical Co., Ltd.
Collaborators
—
Condition
Alzheimer's Disease
Intervention
SHR-1707
Why stopped
Based on the adjustment of the sponsor's R\&D strategy, it is decided to terminate this study in advance.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-13